| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is focusing on innovative treatment development, with a strong emphasis on cancer and obesity therapies, showcasing its commitment to addressing critical healthcare needs. The positive clinical trial results have bolstered the potential for successful drug efficacy, enhancing the outlook for its product pipeline. Additionally, the strong demand and growth potential for its GLP-1 drugs, along with a diversified product portfolio, further contribute to the company's financial success. This strategic direction in product development signals a promising future for Eli Lilly as it adapts to market demands. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 3.4 is extremely bullish. The market sentiment at 1 is bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.6, and the negative at -0.6 on 2026-10-30. The forces of Sentiment towards Fundamentals (4.6), Stock Price Trend (3.4), Sector Price Trend (1.3), and Option Sentiment (0.8) will drive up the price. The forces of Price Level Sentiment (-1), Market Risk Appetite (-1.4), and Valuation Sentiment (-1.4) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-30 | 0%(0.1%) | 1416.35 | 4.98% | 110 | 80 | 63 | 3.2% | 1.24% | 3.4 | 0.7 | 3.5% | 0.9 | Long | 70% | 4.6 | 5.5 |
| 2026-10-29 | 1%(0.1%) | 1372.49 | 4.53% | 106 | 78 | 74 | 6.46% | 0.94% | 2.3 | 1 | 3.2% | 0.9 | Long | 70% | 4.3 | 6.6 |
| 2026-10-28 | 0%(0%) | 1289.19 | 4.31% | 80 | 71 | 52 | 0.6% | 0.62% | 1.3 | -0 | 0.5% | 0.4 | Long | 55% | 3.2 | 6 |
| 2026-10-27 | 0%(0%) | 1281.52 | 4.29% | 80 | 66 | 47 | 0.17% | 0.92% | 1.3 | -0.1 | 0.5% | 0.7 | Wait | 50% | 3.3 | -1 |
| 2026-10-26 | 0%(0%) | 1279.38 | 4.15% | 83 | 69 | 51 | 0.46% | 0.78% | 1.5 | 0 | 1.1% | 0.5 | Long | 65% | 3.4 | -1 |
| 2026-10-25 | 0%(0%) | 1.4 | 0 | 0.7 | 3.6 | -1 | ||||||||||
| 2026-10-24 | 0%(0%) | 1.4 | 0 | 0.9 | 3.7 | -1 | ||||||||||
| 2026-10-23 | 0%(0%) | 1273.51 | 3.99% | 83 | 70 | 32 | -2.56% | 0.77% | 1.4 | -0.4 | 1.4% | 0.9 | Wait | 50% | 3.5 | -1 |
| 2026-10-22 | 0%(0%) | 1306.94 | 3.72% | 104 | 78 | 76 | 2.77% | 1.12% | 2.1 | 0.1 | 1.4% | 1.1 | Long | 70% | 3.5 | -1 |
| 2026-10-21 | 0%(0%) | 1271.72 | 3.32% | 95 | 73 | 15 | -1.05% | 0.68% | 1.7 | 0 | 1.4% | 1.2 | Long | 70% | 3.4 | -1 |
| Long is the preferred trading strategy with 70% chance of being right. Both trend sentiment and hourly trend are very strong. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-10-30 17:01:40 Despite strong earnings, there are concerns regarding the company's high valuation metrics and what that means for future growth. |
| 2026-10-30 17:01:40 The expansion of Medicare access is enhancing Eli Lilly's market potential, particularly related to its obesity drugs. |
| 2026-10-30 17:01:40 Analysts are optimistic about Eli Lilly's future, with raised revenue forecasts reflecting confidence in the company's trajectory. |
| 2026-10-30 17:01:40 With expanding revenues in oncology, immunology, and neuroscience, Eli Lilly is diversifying its product offerings beyond weight-loss drugs. |
| 2026-10-30 17:01:40 Eli Lilly has experienced substantial revenue growth, particularly through its weight-loss drug franchises, indicating strong financial performance. |
| 2026-10-30 15:47:15 Comparing Eli Lilly's market position with diversified companies like Berkshire Hathaway shows differing business strategies and risks. |
| 2026-10-30 15:47:15 Eli Lilly reported earnings that exceeded analyst expectations, indicating strong financial health and performance. |
| 2026-10-30 15:47:15 Key products are significantly contributing to Eli Lilly's financial success, reflecting strong market demand and growth potential. |
| 2026-10-30 15:47:15 Analysts are optimistic about Eli Lilly's future, particularly with anticipated revenue increases due to successful products like Mounjaro and Zepbound. |
| 2026-10-30 15:47:15 Eli Lilly's stock is experiencing significant growth, driven by product success, leading to high analyst expectations. |